§ 13F · FUND PROFILE
Fairmount Funds Management LLC.
AUM · $1.5B (13F)Positions · 12Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$18M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | ORKA | ORUKA THERAPEUTICS INC | 3.71M | $353M | 23.3% | ±0% |
| 2 | DNTH | DIANTHUS THERAPEUTICS INC | 2.54M | $247M | 16.3% | ±0% |
| 3 | DMRA | DAMORA THERAPEUTICS INC | 8.71M | $227M | 15.0% | ±0% |
| 4 | COGT | COGENT BIOSCIENCES INC | 5.50M | $213M | 14.1% | ±0% |
| 5 | JBIO | JADE BIOSCIENCES INC | 4.55M | $101M | 6.7% | ±0% |
| 6 | ELVN | ENLIVEN THERAPEUTICS INC | 1.86M | $94M | 6.2% | ±0% |
| 7 | VRDN | VIRIDIAN THERAPEUTICS INC | 5.09M | $94M | 6.2% | +30% |
| 8 | ZBIO | ZENAS BIOPHARMA INC | 2.36M | $60M | 4.0% | ±0% |
| 9 | CBIO | CRESCENT BIOPHARMA INC. | 2.75M | $49M | 3.3% | ±0% |
| 10 | APGE | APOGEE THERAPEUTICS INC | 299K | $40M | 2.6% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE FAIRMOUNT SIGNAL
AC read
Fairmount Funds Management LLC is a Other fund managing $1.5 billion in assets. The fund runs a focused portfolio of just 12 positions.
Read the full dossier →